D.J. St. Germain’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $838K | Sell |
11,664
-1,090
| -9% | -$84K | 0.03% | 178 |
|
|
2025
Q4 | $1.01M | Sell |
12,754
-248
| -2% | -$19.6K | 0.04% | 171 |
|
|
2025
Q3 | $980K | Sell |
13,002
-2,411
| -16% | -$165K | 0.04% | 164 |
|
|
2025
Q2 | $1.06M | Buy |
15,413
+54
| +0.4% | +$3.54K | 0.05% | 164 |
|
|
2025
Q1 | $1.04M | Sell |
15,359
-233,254
| -94% | -$14M | 0.05% | 158 |
|
|
2024
Q4 | $11.2M | Sell |
248,613
-44,669
| -15% | -$2.51M | 0.51% | 62 |
|
|
2024
Q3 | $18.4M | Sell |
293,282
-2,236
| -0.8% | -$130K | 0.85% | 39 |
|
|
2024
Q2 | $17.5M | Sell |
295,518
-7,091
| -2% | -$444K | 0.84% | 38 |
|
|
2024
Q1 | $24.1M | Sell |
302,609
-67,613
| -18% | -$5.16M | 1.18% | 20 |
|
|
2023
Q4 | $29.2M | Sell |
370,222
-8,708
| -2% | -$620K | 1.52% | 12 |
|
|
2023
Q3 | $26.5M | Sell |
378,930
-10,371
| -3% | -$735K | 1.49% | 15 |
|
|
2023
Q2 | $26.9M | Buy |
+389,301
| New | +$27.7M | 1.42% | 17 |
|
|
2022
Q4 | $8.32M | Buy |
465,257
+91,700
| +25% | +$8.85M | 2.8% | 10 |
|
|
2022
Q3 | $34.6M | Hold |
373,557
| – | – | 2.29% | 8 |
|
|
2022
Q2 | $34.6M | Sell |
373,557
-466
| -0.1% | -$45.5K | 2.29% | 8 |
|
|
2022
Q1 | $37.9M | Sell |
374,023
-5,859
| -2% | -$616K | 2.13% | 8 |
|
|
2021
Q4 | $39.2M | Sell |
379,882
-3,110
| -0.8% | -$287K | 2.15% | 8 |
|
|
2021
Q3 | $32.5M | Sell |
382,992
-8,787
| -2% | -$736K | 2% | 10 |
|
|
2021
Q2 | $32.7M | Sell |
391,779
-4,270
| -1% | -$350K | 2.05% | 9 |
|
|
2021
Q1 | $29.8M | Sell |
396,049
-19,907
| -5% | -$1.45M | 2.01% | 9 |
|
|
2020
Q4 | $28.4M | Buy |
415,956
+37,401
| +10% | +$2.43M | 2.03% | 8 |
|
|
2020
Q3 | $22.1M | Buy |
378,555
+39,923
| +12% | +$2.48M | 1.79% | 12 |
|
|
2020
Q2 | $22M | Buy |
338,632
+3,707
| +1% | +$233K | 1.93% | 11 |
|
|
2020
Q1 | $19.9M | Sell |
334,925
-1,623
| -0.5% | -$108K | 1.95% | 14 |
|
|
2019
Q4 | $25M | Buy |
336,548
+67,393
| +25% | +$4.73M | 2.1% | 10 |
|
|
2019
Q3 | $17M | Buy |
269,155
+92
| +0% | +$5.45K | 1.83% | 17 |
|
|
2019
Q2 | $14.7M | Buy |
269,063
+1,310
| +0.5% | +$70.5K | 1.6% | 22 |
|
|
2019
Q1 | $14.4M | Buy |
267,753
+28,917
| +12% | +$1.78M | 1.57% | 22 |
|
|
2018
Q4 | $15.6M | Buy |
238,836
+26,599
| +13% | +$1.99M | 1.86% | 15 |
|
|
2018
Q3 | $16.7M | Buy |
212,237
+3,003
| +1% | +$215K | 1.87% | 19 |
|
|
2018
Q2 | $13.5M | Buy |
209,234
+29,730
| +17% | +$1.96M | 1.6% | 24 |
|
|
2018
Q1 | $11.2M | Buy |
179,504
+25,076
| +16% | +$1.8M | 1.41% | 25 |
|
|
2017
Q4 | $11.2M | Sell |
154,428
-60,407
| -28% | -$4.39M | 1.34% | 29 |
|
|
2017
Q3 | $17.5M | Buy |
214,835
+6,432
| +3% | +$509K | 2.19% | 16 |
|
|
2017
Q2 | $16.8M | Buy |
208,403
+4,712
| +2% | +$372K | 2.24% | 14 |
|
|
2017
Q1 | $16M | Buy |
203,691
+7,185
| +4% | +$574K | 2.23% | 14 |
|
|
2016
Q4 | $15.5M | Buy |
196,506
+81,518
| +71% | +$6.6M | 2.1% | 14 |
|
|
2016
Q3 | $10.2M | Buy |
114,988
+5,601
| +5% | +$529K | 1.43% | 29 |
|
|
2016
Q2 | $10.5M | Buy |
109,387
+107,450
| +5,547% | +$10.7M | 1.46% | 29 |
|
|
2016
Q1 | $201K | Buy |
+1,937
| New | +$188K | 0.03% | 142 |
|
Other funds holding CVS
VCM
VPM
D.J. St. Germain's CVS Position: Q1 2026 in Review
D.J. St. Germain reduced its CVS Health (CVS) stake by 8.5% in Q1 2026, selling an estimated $84K and leaving 11,664 shares worth $838K. The position accounts for 0.03% of the portfolio, ranked #178.
D.J. St. Germain first reported a position in CVS in Q1 2016 and has held it in 40 quarters since. The position peaked at $39.2M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- D.J. St. Germain held 11,664 shares of CVS Health worth $838K as of Q1 2026.
- D.J. St. Germain sold 1,090 CVS Health shares in Q1 2026, an estimated $84K.
- CVS Health made up 0.03% of D.J. St. Germain's portfolio in Q1 2026, its #178 holding.
- D.J. St. Germain first reported a position in CVS Health in Q1 2016 and has held it in 40 quarters since.
- D.J. St. Germain's CVS Health position peaked at $39.2M in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on D.J. St. Germain's 13F filing for Q1 2026, filed 13 Apr 2026.